US approves UCB’s Cimzia for psoriasis
admin 29th May 2018 Uncategorised 0Drug is the first Fc-free, PEGylated anti-TNF treatment option for this indication and marks UCB’s entry into immuno-dermatology
More: US approves UCB’s Cimzia for psoriasis
Source: News